nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC6—Dactinomycin—muscle cancer	0.139	0.149	CbGbCtD
Probenecid—ABCC11—Methotrexate—muscle cancer	0.0905	0.0966	CbGbCtD
Probenecid—ABCC6—Etoposide—muscle cancer	0.0786	0.0839	CbGbCtD
Probenecid—ABCC6—Doxorubicin—muscle cancer	0.0536	0.0572	CbGbCtD
Probenecid—ABCC3—Vincristine—muscle cancer	0.0412	0.044	CbGbCtD
Probenecid—ABCC1—Dactinomycin—muscle cancer	0.0411	0.0439	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—muscle cancer	0.0397	0.0424	CbGbCtD
Probenecid—SLC16A1—Methotrexate—muscle cancer	0.0397	0.0424	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—muscle cancer	0.0391	0.0417	CbGbCtD
Probenecid—ABCC3—Etoposide—muscle cancer	0.0378	0.0403	CbGbCtD
Probenecid—ABCC3—Doxorubicin—muscle cancer	0.0258	0.0275	CbGbCtD
Probenecid—ABCC1—Vincristine—muscle cancer	0.0253	0.027	CbGbCtD
Probenecid—ABCC3—Methotrexate—muscle cancer	0.025	0.0266	CbGbCtD
Probenecid—ABCC1—Etoposide—muscle cancer	0.0232	0.0248	CbGbCtD
Probenecid—SLC22A11—Methotrexate—muscle cancer	0.0205	0.0219	CbGbCtD
Probenecid—SLC22A7—Methotrexate—muscle cancer	0.0195	0.0208	CbGbCtD
Probenecid—ABCC4—Methotrexate—muscle cancer	0.0191	0.0204	CbGbCtD
Probenecid—ABCC2—Vincristine—muscle cancer	0.0187	0.02	CbGbCtD
Probenecid—ABCC2—Etoposide—muscle cancer	0.0172	0.0183	CbGbCtD
Probenecid—ABCC1—Doxorubicin—muscle cancer	0.0158	0.0169	CbGbCtD
Probenecid—ABCC1—Methotrexate—muscle cancer	0.0153	0.0164	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—muscle cancer	0.0137	0.0146	CbGbCtD
Probenecid—SLC22A8—Methotrexate—muscle cancer	0.0119	0.0127	CbGbCtD
Probenecid—ABCC2—Doxorubicin—muscle cancer	0.0117	0.0125	CbGbCtD
Probenecid—ABCC2—Methotrexate—muscle cancer	0.0113	0.0121	CbGbCtD
Probenecid—ABCB1—Dactinomycin—muscle cancer	0.00992	0.0106	CbGbCtD
Probenecid—SLC22A6—Methotrexate—muscle cancer	0.0083	0.00886	CbGbCtD
Probenecid—CYP2C8—Etoposide—muscle cancer	0.00827	0.00883	CbGbCtD
Probenecid—ALB—Methotrexate—muscle cancer	0.00707	0.00755	CbGbCtD
Probenecid—ABCB1—Vincristine—muscle cancer	0.00611	0.00652	CbGbCtD
Probenecid—ABCB1—Etoposide—muscle cancer	0.0056	0.00597	CbGbCtD
Probenecid—ABCB1—Doxorubicin—muscle cancer	0.00382	0.00407	CbGbCtD
Probenecid—ABCB1—Methotrexate—muscle cancer	0.0037	0.00395	CbGbCtD
Probenecid—CYP3A4—Vincristine—muscle cancer	0.00366	0.00391	CbGbCtD
Probenecid—ABCC6—Podofilox—Etoposide—muscle cancer	0.00336	1	CbGdCrCtD
Probenecid—CYP3A4—Etoposide—muscle cancer	0.00335	0.00358	CbGbCtD
Probenecid—SLC22A12—renal system—muscle cancer	0.0029	0.0551	CbGeAlD
Probenecid—ABCC11—embryo—muscle cancer	0.00278	0.0529	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—muscle cancer	0.00229	0.00244	CbGbCtD
Probenecid—SLC2A9—renal system—muscle cancer	0.00199	0.0379	CbGeAlD
Probenecid—PANX1—tendon—muscle cancer	0.00171	0.0326	CbGeAlD
Probenecid—PANX1—vagina—muscle cancer	0.00159	0.0303	CbGeAlD
Probenecid—PANX1—head—muscle cancer	0.00147	0.028	CbGeAlD
Probenecid—PANX1—testis—muscle cancer	0.00142	0.027	CbGeAlD
Probenecid—ABCC11—testis—muscle cancer	0.00136	0.0259	CbGeAlD
Probenecid—SLC2A9—testis—muscle cancer	0.00129	0.0245	CbGeAlD
Probenecid—ABCC6—renal system—muscle cancer	0.00121	0.023	CbGeAlD
Probenecid—SLC10A1—renal system—muscle cancer	0.0011	0.0209	CbGeAlD
Probenecid—SLC16A7—cardiac atrium—muscle cancer	0.00105	0.02	CbGeAlD
Probenecid—SLCO1C1—renal system—muscle cancer	0.00103	0.0196	CbGeAlD
Probenecid—SLC22A11—renal system—muscle cancer	0.001	0.0191	CbGeAlD
Probenecid—SLC22A7—renal system—muscle cancer	0.000977	0.0186	CbGeAlD
Probenecid—SLC16A7—tendon—muscle cancer	0.000917	0.0174	CbGeAlD
Probenecid—SLC22A2—renal system—muscle cancer	0.00087	0.0166	CbGeAlD
Probenecid—SLC16A7—vagina—muscle cancer	0.00085	0.0162	CbGeAlD
Probenecid—ABCC6—head—muscle cancer	0.000809	0.0154	CbGeAlD
Probenecid—SLC16A7—head—muscle cancer	0.000786	0.015	CbGeAlD
Probenecid—SLC16A7—testis—muscle cancer	0.000759	0.0144	CbGeAlD
Probenecid—SLC16A1—renal system—muscle cancer	0.000747	0.0142	CbGeAlD
Probenecid—ABCC5—cardiac atrium—muscle cancer	0.000736	0.014	CbGeAlD
Probenecid—SLC10A1—head—muscle cancer	0.000734	0.014	CbGeAlD
Probenecid—SLC10A1—testis—muscle cancer	0.000709	0.0135	CbGeAlD
Probenecid—SLCO1C1—head—muscle cancer	0.00069	0.0131	CbGeAlD
Probenecid—ABCC3—renal system—muscle cancer	0.00069	0.0131	CbGeAlD
Probenecid—SLC16A1—cardiac atrium—muscle cancer	0.000669	0.0127	CbGeAlD
Probenecid—SLCO1C1—testis—muscle cancer	0.000666	0.0127	CbGeAlD
Probenecid—ABCC5—tendon—muscle cancer	0.000641	0.0122	CbGeAlD
Probenecid—SLC22A7—testis—muscle cancer	0.000632	0.012	CbGeAlD
Probenecid—ABCC5—bone marrow—muscle cancer	0.000621	0.0118	CbGeAlD
Probenecid—SLC22A1—renal system—muscle cancer	0.000615	0.0117	CbGeAlD
Probenecid—ABCC5—vagina—muscle cancer	0.000595	0.0113	CbGeAlD
Probenecid—SLCO1A2—renal system—muscle cancer	0.000592	0.0113	CbGeAlD
Probenecid—SLC16A1—tendon—muscle cancer	0.000583	0.0111	CbGeAlD
Probenecid—ABCC4—renal system—muscle cancer	0.000569	0.0108	CbGeAlD
Probenecid—SLC22A8—renal system—muscle cancer	0.000565	0.0108	CbGeAlD
Probenecid—ABCC2—renal system—muscle cancer	0.000551	0.0105	CbGeAlD
Probenecid—ABCC5—testis—muscle cancer	0.000531	0.0101	CbGeAlD
Probenecid—SLC16A1—head—muscle cancer	0.0005	0.00952	CbGeAlD
Probenecid—SLC16A1—testis—muscle cancer	0.000483	0.0092	CbGeAlD
Probenecid—ABCC3—head—muscle cancer	0.000462	0.00879	CbGeAlD
Probenecid—ABCC3—testis—muscle cancer	0.000446	0.00849	CbGeAlD
Probenecid—SLC22A1—vagina—muscle cancer	0.000445	0.00847	CbGeAlD
Probenecid—ABCC4—tendon—muscle cancer	0.000445	0.00846	CbGeAlD
Probenecid—ABCC1—cardiac atrium—muscle cancer	0.000435	0.00828	CbGeAlD
Probenecid—ABCC4—bone marrow—muscle cancer	0.000431	0.0082	CbGeAlD
Probenecid—ABCC2—tendon—muscle cancer	0.00043	0.00819	CbGeAlD
Probenecid—SLC22A5—renal system—muscle cancer	0.000427	0.00813	CbGeAlD
Probenecid—CYP2C8—renal system—muscle cancer	0.000413	0.00787	CbGeAlD
Probenecid—SLC22A1—head—muscle cancer	0.000411	0.00783	CbGeAlD
Probenecid—SLCO1A2—head—muscle cancer	0.000396	0.00754	CbGeAlD
Probenecid—SLCO1A2—testis—muscle cancer	0.000382	0.00728	CbGeAlD
Probenecid—SLC22A5—cardiac atrium—muscle cancer	0.000382	0.00728	CbGeAlD
Probenecid—ABCC4—head—muscle cancer	0.000381	0.00725	CbGeAlD
Probenecid—ALB—testis—muscle cancer	0.00038	0.00724	CbGeAlD
Probenecid—ABCC1—tendon—muscle cancer	0.000379	0.00722	CbGeAlD
Probenecid—SLC22A8—head—muscle cancer	0.000378	0.0072	CbGeAlD
Probenecid—ABCC4—testis—muscle cancer	0.000368	0.00701	CbGeAlD
Probenecid—ABCC2—testis—muscle cancer	0.000356	0.00678	CbGeAlD
Probenecid—ABCC1—vagina—muscle cancer	0.000352	0.0067	CbGeAlD
Probenecid—CYP2C19—vagina—muscle cancer	0.000343	0.00653	CbGeAlD
Probenecid—SLC22A5—tendon—muscle cancer	0.000333	0.00635	CbGeAlD
Probenecid—ABCC1—testis—muscle cancer	0.000314	0.00598	CbGeAlD
Probenecid—SLC22A5—vagina—muscle cancer	0.000309	0.00589	CbGeAlD
Probenecid—Aplastic anaemia—Dactinomycin—muscle cancer	0.000307	0.043	CcSEcCtD
Probenecid—CYP2C8—vagina—muscle cancer	0.000299	0.0057	CbGeAlD
Probenecid—CYP3A4—renal system—muscle cancer	0.00028	0.00533	CbGeAlD
Probenecid—SLC22A5—testis—muscle cancer	0.000276	0.00526	CbGeAlD
Probenecid—CYP2C8—testis—muscle cancer	0.000267	0.00509	CbGeAlD
Probenecid—ABCB1—embryo—muscle cancer	0.000262	0.00499	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.000214	0.03	CcSEcCtD
Probenecid—ABCB1—renal system—muscle cancer	0.000198	0.00377	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.000181	0.0254	CcSEcCtD
Probenecid—Erythema multiforme—Dactinomycin—muscle cancer	0.000155	0.0218	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000155	0.0217	CcSEcCtD
Probenecid—Flushing—Dactinomycin—muscle cancer	0.000152	0.0214	CcSEcCtD
Probenecid—ABCB1—bone marrow—muscle cancer	0.00015	0.00285	CbGeAlD
Probenecid—Alopecia—Dactinomycin—muscle cancer	0.000145	0.0203	CcSEcCtD
Probenecid—ABCB1—vagina—muscle cancer	0.000144	0.00273	CbGeAlD
Probenecid—Aplastic anaemia—Methotrexate—muscle cancer	0.000133	0.0187	CcSEcCtD
Probenecid—ABCB1—head—muscle cancer	0.000133	0.00253	CbGeAlD
Probenecid—Anaemia—Dactinomycin—muscle cancer	0.000132	0.0185	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000131	0.0184	CcSEcCtD
Probenecid—Alopecia—Vincristine—muscle cancer	0.00013	0.0182	CcSEcCtD
Probenecid—ABCB1—testis—muscle cancer	0.000128	0.00244	CbGeAlD
Probenecid—Leukopenia—Dactinomycin—muscle cancer	0.000128	0.0179	CcSEcCtD
Probenecid—Anaemia—Vincristine—muscle cancer	0.000118	0.0165	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—muscle cancer	0.000115	0.0162	CcSEcCtD
Probenecid—Leukopenia—Vincristine—muscle cancer	0.000114	0.016	CcSEcCtD
Probenecid—Erythema multiforme—Etoposide—muscle cancer	0.000112	0.0157	CcSEcCtD
Probenecid—Anorexia—Dactinomycin—muscle cancer	0.000111	0.0156	CcSEcCtD
Probenecid—Flushing—Etoposide—muscle cancer	0.00011	0.0155	CcSEcCtD
Probenecid—Alopecia—Etoposide—muscle cancer	0.000105	0.0147	CcSEcCtD
Probenecid—Anaphylactic shock—Vincristine—muscle cancer	0.000104	0.0146	CcSEcCtD
Probenecid—Decreased appetite—Dactinomycin—muscle cancer	0.000101	0.0142	CcSEcCtD
Probenecid—Pain—Dactinomycin—muscle cancer	9.97e-05	0.014	CcSEcCtD
Probenecid—Anorexia—Vincristine—muscle cancer	9.93e-05	0.0139	CcSEcCtD
Probenecid—Anaemia—Etoposide—muscle cancer	9.56e-05	0.0134	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Methotrexate—muscle cancer	9.26e-05	0.013	CcSEcCtD
Probenecid—Leukopenia—Etoposide—muscle cancer	9.26e-05	0.013	CcSEcCtD
Probenecid—Body temperature increased—Dactinomycin—muscle cancer	9.22e-05	0.0129	CcSEcCtD
Probenecid—Decreased appetite—Vincristine—muscle cancer	9.06e-05	0.0127	CcSEcCtD
Probenecid—Pain—Vincristine—muscle cancer	8.91e-05	0.0125	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—muscle cancer	8.59e-05	0.012	CcSEcCtD
Probenecid—Anaphylactic shock—Etoposide—muscle cancer	8.44e-05	0.0118	CcSEcCtD
Probenecid—Body temperature increased—Vincristine—muscle cancer	8.24e-05	0.0115	CcSEcCtD
Probenecid—Anorexia—Etoposide—muscle cancer	8.04e-05	0.0113	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	8.02e-05	0.0112	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—muscle cancer	7.86e-05	0.011	CcSEcCtD
Probenecid—Hypersensitivity—Vincristine—muscle cancer	7.68e-05	0.0108	CcSEcCtD
Probenecid—Haematuria—Methotrexate—muscle cancer	7.56e-05	0.0106	CcSEcCtD
Probenecid—Vomiting—Dactinomycin—muscle cancer	7.41e-05	0.0104	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—muscle cancer	7.34e-05	0.0103	CcSEcCtD
Probenecid—Pain—Etoposide—muscle cancer	7.22e-05	0.0101	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—muscle cancer	7.11e-05	0.00997	CcSEcCtD
Probenecid—Nausea—Dactinomycin—muscle cancer	6.93e-05	0.00971	CcSEcCtD
Probenecid—Dizziness—Vincristine—muscle cancer	6.89e-05	0.00966	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	6.8e-05	0.00954	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—muscle cancer	6.73e-05	0.00943	CcSEcCtD
Probenecid—Urticaria—Etoposide—muscle cancer	6.7e-05	0.0094	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—muscle cancer	6.67e-05	0.00935	CcSEcCtD
Probenecid—Vomiting—Vincristine—muscle cancer	6.62e-05	0.00929	CcSEcCtD
Probenecid—Dermatitis—Vincristine—muscle cancer	6.56e-05	0.0092	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—muscle cancer	6.54e-05	0.00918	CcSEcCtD
Probenecid—Headache—Vincristine—muscle cancer	6.53e-05	0.00915	CcSEcCtD
Probenecid—Alopecia—Methotrexate—muscle cancer	6.29e-05	0.00882	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—muscle cancer	6.22e-05	0.00872	CcSEcCtD
Probenecid—Nausea—Vincristine—muscle cancer	6.19e-05	0.00868	CcSEcCtD
Probenecid—Pruritus—Etoposide—muscle cancer	5.97e-05	0.00837	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—muscle cancer	5.83e-05	0.00817	CcSEcCtD
Probenecid—Anaemia—Methotrexate—muscle cancer	5.72e-05	0.00803	CcSEcCtD
Probenecid—Flushing—Doxorubicin—muscle cancer	5.72e-05	0.00802	CcSEcCtD
Probenecid—Dizziness—Etoposide—muscle cancer	5.58e-05	0.00782	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—muscle cancer	5.54e-05	0.00777	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—muscle cancer	5.44e-05	0.00763	CcSEcCtD
Probenecid—Vomiting—Etoposide—muscle cancer	5.37e-05	0.00752	CcSEcCtD
Probenecid—Dermatitis—Etoposide—muscle cancer	5.32e-05	0.00745	CcSEcCtD
Probenecid—Headache—Etoposide—muscle cancer	5.29e-05	0.00741	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—muscle cancer	5.06e-05	0.00709	CcSEcCtD
Probenecid—Nausea—Etoposide—muscle cancer	5.01e-05	0.00703	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—muscle cancer	4.96e-05	0.00695	CcSEcCtD
Probenecid—Anorexia—Methotrexate—muscle cancer	4.82e-05	0.00676	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—muscle cancer	4.8e-05	0.00673	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—muscle cancer	4.39e-05	0.00616	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—muscle cancer	4.38e-05	0.00614	CcSEcCtD
Probenecid—Pain—Methotrexate—muscle cancer	4.32e-05	0.00606	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—muscle cancer	4.17e-05	0.00585	CcSEcCtD
Probenecid—Urticaria—Methotrexate—muscle cancer	4.02e-05	0.00563	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—muscle cancer	4e-05	0.0056	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—muscle cancer	3.81e-05	0.00534	CcSEcCtD
Probenecid—Pain—Doxorubicin—muscle cancer	3.74e-05	0.00525	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—muscle cancer	3.72e-05	0.00522	CcSEcCtD
Probenecid—Pruritus—Methotrexate—muscle cancer	3.58e-05	0.00501	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—muscle cancer	3.48e-05	0.00488	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—muscle cancer	3.46e-05	0.00485	CcSEcCtD
Probenecid—Dizziness—Methotrexate—muscle cancer	3.34e-05	0.00469	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—muscle cancer	3.23e-05	0.00452	CcSEcCtD
Probenecid—Vomiting—Methotrexate—muscle cancer	3.21e-05	0.00451	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—muscle cancer	3.18e-05	0.00446	CcSEcCtD
Probenecid—Headache—Methotrexate—muscle cancer	3.17e-05	0.00444	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—muscle cancer	3.1e-05	0.00434	CcSEcCtD
Probenecid—Nausea—Methotrexate—muscle cancer	3e-05	0.00421	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—muscle cancer	2.89e-05	0.00406	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—muscle cancer	2.78e-05	0.0039	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—muscle cancer	2.76e-05	0.00387	CcSEcCtD
Probenecid—Headache—Doxorubicin—muscle cancer	2.74e-05	0.00384	CcSEcCtD
Probenecid—Nausea—Doxorubicin—muscle cancer	2.6e-05	0.00365	CcSEcCtD
